APA

Guillemot J., Thouënnon E., Guérin M., Vallet-Erdtmann V., Ravni A., Montéro-Hadjadje M., Lefebvre H., Klein M., Muresan M., Seidah N. G., Anouar Y. & Yon L. (20120605). Differential expression and processing of secretogranin II in relation to the status of pheochromocytoma: implications for the production of the tumoral marker EM66. : Journal of molecular endocrinology.

Chicago

Guillemot J, Thouënnon E, Guérin M, Vallet-Erdtmann V, Ravni A, Montéro-Hadjadje M, Lefebvre H, Klein M, Muresan M, Seidah N G, Anouar Y and Yon L. 20120605. Differential expression and processing of secretogranin II in relation to the status of pheochromocytoma: implications for the production of the tumoral marker EM66. : Journal of molecular endocrinology.

Harvard

Guillemot J., Thouënnon E., Guérin M., Vallet-Erdtmann V., Ravni A., Montéro-Hadjadje M., Lefebvre H., Klein M., Muresan M., Seidah N. G., Anouar Y. and Yon L. (20120605). Differential expression and processing of secretogranin II in relation to the status of pheochromocytoma: implications for the production of the tumoral marker EM66. : Journal of molecular endocrinology.

MLA

Guillemot J, Thouënnon E, Guérin M, Vallet-Erdtmann V, Ravni A, Montéro-Hadjadje M, Lefebvre H, Klein M, Muresan M, Seidah N G, Anouar Y and Yon L. Differential expression and processing of secretogranin II in relation to the status of pheochromocytoma: implications for the production of the tumoral marker EM66. : Journal of molecular endocrinology. 20120605.